| |
Unrestricted |
Temporarily Restricted |
Permanently Restricted |
| |
General Fund |
Endowment Fund |
Total |
General Fund |
Endowment Fund |
Total |
Endowment Fund |
Total |
|
SUPPORT, REVENUES, AND GAINS |
| Products distributed and sold |
$ 18,553,865 |
$ |
$ 18,553,865 |
$ |
$ |
$ |
$ |
$ 18,553,865 |
| Contributions and bequests |
926,874 |
1,409,990 |
2,336,864 |
|
10,210 |
10,210 |
|
2,347,074 |
| Interest and dividends |
602,173 |
1,301,227 |
1,903,400 |
|
|
|
|
1,903,400 |
| Grants |
735,578 |
|
735,578 |
|
|
|
|
735,578 |
| Gain on investments |
68,693 |
7,470,022 |
7,538,715 |
|
|
|
207,897 |
7,746,612 |
| Miscellaneous income |
1,219,489 |
997 |
1,220,486 |
|
|
|
|
1,220,486 |
| Net assets released from restrictions |
11,973 |
234,464 |
246,437 |
(11,973) |
(234,464) |
(246,437) |
|
|
| Total Support, Revenues, and Gains |
22,118,645 |
10,416,700 |
32,535,345 |
(11,973) |
(224,254) |
(236,227) |
207,897 |
32,507,015 |
| |
EXPENSES AND LOSSES |
| Costs of products distributed and sold |
14,061,305 |
|
14,061,305 |
|
|
|
|
14,061,305 |
| General and administrative |
4,228,090 |
289,761 |
4,517,851 |
|
|
|
|
4,517,851 |
| Program support |
553,571 |
2,493,656 |
3,047,227 |
|
|
|
|
3,047,227 |
| Fundraising and development |
844,291 |
|
844,291 |
|
|
|
|
844,291 |
| Miscellaneous expense |
153,630 |
|
153,630 |
|
|
|
|
153,630 |
| Investment fees |
|
256,063 |
256,063 |
|
|
|
|
256,063 |
| Total Expenses and Losses |
19,840,887 |
3,039,480 |
22,880,367 |
0 |
0 |
0 |
0 |
22,880,367 |
| Change in net assets before effect of adoption of FASB Statement no. 158 |
2,277,758 |
7,377,220 |
9,654,978 |
(11,973) |
(224,254) |
(236,227) |
207,897 |
9,626,648 |
| Effect of adoption of recognition and measurement date provisions of FASB Statement No. 158 |
(2,702,666) |
0 |
(2,702,666) |
0 |
0 |
0 |
0 |
(2,702,666) |
| |
CHANGE IN NET ASSETS |
(424,908) |
7,377,220 |
6,952,312 |
(11,973) |
(224,254) |
(236,227) |
207,897 |
6,923,982 |
| |
NET ASSETS, BEGINNING OF YEAR |
25,234,011 |
68,285,881 |
93,519,892 |
91,655 |
283,728 |
375,383 |
2,841,414 |
96,736,689 |
| |
NET ASSETS, END OF YEAR |
$ 24,809,103 |
$ 75,663,101 |
$ 100,472,204 |
$ 79,682 |
$ 59,474 |
$ 139,156 |
$ 3,049,311 |
$ 103,660,671 |
| |
Unrestricted |
Temporarily Restricted |
Permanently Restricted |
| |
General Fund |
Endowment Fund |
Total |
General Fund |
Endowment Fund |
Total |
Endowment Fund |
Total |
|
SUPPORT, REVENUES, AND GAINS |
| Products distributed and sold |
$ 21,803,031 |
$ |
$ 21,803,031 |
$ |
$ |
$ |
$ |
$ 21,803,031 |
| Contributions and bequests |
1,069,661 |
1,952,751 |
3,022,412 |
|
25,843 |
25,843 |
|
3,048,255 |
| Interest and dividends |
501,853 |
1,157,074 |
1,658,927 |
|
|
|
|
1,658,927 |
| Grants |
182,188 |
|
182,188 |
|
|
|
|
182,188 |
| Gain on investments |
62,769 |
3,641,165 |
3,703,934 |
|
|
|
77,193 |
3,781,127 |
| Miscellaneous income |
2,243,088 |
2,508 |
2,245,596 |
|
|
|
|
2,245,596 |
| Net assets released from restrictions |
7,107 |
|
7,107 |
(7,107) |
|
(7,107) |
|
|
| Total Support, Revenues, and Gains |
25,869,697 |
6,753,498 |
32,623,195 |
(7,107) |
25,843 |
18,736 |
77,193 |
32,719,124 |
| |
EXPENSES AND LOSSES |
| Costs of products distributed and sold |
16,395,623 |
|
16,395,623 |
|
|
|
|
16,395,623 |
| General and administrative |
4,663,722 |
87 |
4,663,809 |
|
|
|
|
4,663,809 |
| Program support |
2,576,990 |
336,511 |
2,913,501 |
|
|
|
|
2,913,501 |
| Fundraising and development |
878,159 |
|
878,159 |
|
|
|
|
878,159 |
| Miscellaneous expense |
215,384 |
|
215,384 |
|
|
|
|
215,384 |
| Investment fees |
|
251,629 |
251,629 |
|
|
|
|
251,629 |
| Total Expenses and Losses |
24,729,878 |
588,227 |
25,318,105 |
0 |
0 |
0 |
0 |
25,318,105 |
| |
CHANGE IN NET ASSETS |
1,139,819 |
6,165,271 |
7,305,090 |
(7,107) |
25,843 |
18,736 |
77,193 |
7,401,019 |
| |
NET ASSETS, BEGINNING OF YEAR |
24,094,192 |
62,120,610 |
86,214,802 |
98,762 |
257,885 |
356,647 |
2,764,221 |
89,335,670 |
| |
NET ASSETS, END OF YEAR |
$ 25,234,011 |
$ 68,285,881 |
$ 93,519,892 |
$ 91,655 |
$ 283,728 |
$ 375,383 |
$ 2,841,414 |
$ 96,736,689 |